Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug interaction between DWC20141 and DWC20142
NCT02369302Phase 1Completed
- Sponsor
- Daewoong Pharmaceutical
- Start
- Jan 2015
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial comparing Treatment A: DWC20141, Treatment B: DWC20142 and Treatment C: DWC20141 + DWC20142 (3 arms). Primary endpoints: Maximum observed steady-state plasma concentration and Area under the plasma concentration-time curve over a dosing interval at steady state. Started Jan 2015; status: completed.
02
Drugs
DWC-20141DWC20142
Beyond the preview
Go deeper on NCT02369302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02369302.